Skip to content

Study · Non-randomized trial · n = 54 · 1974

1 result

A trial of corticotrophin gelatin injection in acute optic neuritis.

Bowden AN, Bowden PM, Friedmann AI, Perkin GD, Rose FC

Journal of neurology, neurosurgery, and psychiatry1 Aug 1974Cited by 30 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In acute unilateral optic neuritis, corticotrophin gelatin injections produced no significant overall differences from inert injections through two years.

    In plain wordsIn acute optic neuritis, corticotrophin gelatin injections did not significantly differ from inert injections through two years.

    Outcome
    No significant changeOverall optic neuritis outcomes
    Study

    n = 54

    Comparator
    Inert injections
    Outcome group
    Vision and retina · Eye
    Studied dose
    Dose not stated · injection · 30 daysAs given in this study (human).

    Source sentences

    Summary
    No significant differences were found between treated and control groups at intervals up to two years from the start of the trial.
    3 context sentences
    Summary · context
    The effect of a 30 day course of corticotrophin gelatin injections on the natural history of acute unilateral optic neuritis in 27 patients is reported.
    Summary · context
    A further 27 patients received inert injections in a double-blind control.
    Summary · context
    Measurements were made on visual acuity, visual field, macular threshold, and colour vision, and the development of optic atrophy and other neurological episodes was recorded.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.